Skip to main content
Migraine & Headache patient education

Medication Overuse & Rebound Headache

When migraine or other headaches keep returning, medication can become part of getting through the day. You deserve an assessment that considers both your medication pattern and what may be contributing to the recurring pain.

The dura—the protective membrane around the brain that continues around the spinal cord—is one of the major pain-sensitive tissues inside the skull. Its sensory nerves respond to mechanical forces as well as chemical signals. This makes the relationship between tissue tension and migraine signalling an important area to consider.

Frequent use of certain medicines taken for attacks can also contribute to medication-overuse headache, often called rebound headache. We consider this alongside your migraine history and clinical findings, with any medication changes planned with your prescribing clinician.

Our aim is to resolve recurring migraine and headaches. Where complete resolution is not achieved, we work towards substantially fewer attacks, lower intensity and less disruption—with the possibility of reducing your need for medication as your condition improves.

Understanding Medication Overuse

Medication-overuse headache can develop when certain medicines used to treat migraine or headache attacks are taken frequently over several months. It can occur alongside the original migraine or headache condition.

Clinicians consider this diagnosis when headaches occur on 15 or more days a month, with regular overuse of attack medication for more than three months. The medication-use threshold depends on the medicine:

  • Triptans, opioids and combination painkillers: 10 or more days a month.
  • Paracetamol and anti-inflammatory painkillers such as ibuprofen: 15 or more days a month.

These figures refer to days of use, not the number of tablets. Using a mixture of medicines can also contribute. Daily preventive treatment is assessed differently from medicines taken to treat individual attacks.

Pain returning after medication wears off does not, by itself, establish medication-overuse headache. Recording your headache days and medication use helps your prescribing clinician clarify what is happening and plan appropriate treatment.

A Distinctive Approach to Cranial and Dural Relationships

Experimental research connects force-sensitive channels in meningeal nerves with migraine-related signalling, including CGRP. Mechanical sensitivity and chemical signalling can also reinforce one another.

NasalRx offers a distinctive approach to these relationships. Using brief, controlled balloon inflation within the nasal passages, treatment aims to address the cranial and facial restrictions identified in our assessment. We also assess the upper neck and its connection to the spinal dura through the myodural bridge.

Our clinical model proposes that easing restrictions within these connected structures may reduce associated dural tension and mechanical input into migraine pain pathways—potentially influencing an earlier contributor to the cycle of recurring attacks.

Assessing the Pattern and Reviewing Your Progress

Your assessment brings together the history of your migraine or other headaches, medication use and the symptoms that accompany each attack. We examine cranial and facial relationships, upper-neck movement and muscle tension to consider whether our approach is appropriate for you.

Before and after treatment, we compare cranial and facial palpation findings alongside movement and your own experience of symptoms. Palpation is a clinical assessment based on touch and practitioner judgement; we consider these findings together with how you feel and function.

Over time, we look for changes that matter in daily life: fewer migraine and headache days, less intense or shorter attacks, improved ability to work and enjoy activities, and a reduced need for attack medication.

If medication overuse is contributing, an individual medication-management plan remains important. We aim to address the mechanical contributors considered in our clinical model alongside that care. If your need for medication falls, your prescribing clinician can help you review treatment safely.

Frequently Asked Questions

Should I stop my migraine medication before an assessment?

You do not need to stop prescribed medication to arrange an assessment. Bring a list of what you take and, if possible, a record of the days you use it. If medication overuse is suspected, discuss an individual plan with your prescribing clinician rather than making changes on your own.

Does pain returning after medication mean I have rebound headache?

Not necessarily. An attack may return or continue for several reasons. Medication-overuse headache is assessed using your headache pattern, the medicines involved and how frequently and how long you have used them.

Can NasalRx help me reduce my need for migraine medication?

Reducing the need for medication is an important goal of our care. Our clinical model considers whether addressing cranial, facial and upper-neck restrictions may help reduce recurring migraine and other headaches. If attacks substantially reduce or cease, you can review your medication needs with your prescribing clinician. NasalRx is not an established treatment for medication-overuse headache itself.

Move Towards Life Beyond Recurring Attacks

If your days are increasingly shaped by migraine, headaches and the need for medication, we would welcome the opportunity to assess you. Our aim is to help you regain more of your life—working towards resolution of recurring attacks, or a substantial reduction in their frequency, intensity and impact.

An assessment at Cranial Solutions explores your symptoms, cranial and facial findings, and upper-neck relationships to consider whether NasalRx and our wider approach are appropriate for you.

Book an assessment
Research & Further Reading

These references support the medication-overuse guidance and the discussion of meningeal pain sensitivity and signalling. Human surgical observations and animal experiments inform the proposed mechanical model. They do not establish that NasalRx reduces dural tension, CGRP release or medication-overuse headache.